Increasing Consumer Adoption To Fuel Demand For Electroconvulsive Therapy Devices Market

19/feb/2020 12:23:54 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Though this treatment is said to be effective for many psychiatric disorder there are significant controversies related to this procedure. Some study have concluded ECT procedures just marginally more effective that other placebo procedures. This procedure is viewed harmful by general population and mental health professionals.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12127  

Despite of all the controversies ECT is used by the US and is endorsed by the American Psychiatric Association. Professional associations of Canada, Netherlands, Germany, Austria, Denmark and India have professional guidelines to use ECT.

ECT is performed on only selective patients with high degree of symptoms of severity and functional physical or mental disorders. It is also given to the patient who require treatment response urgently e.g. patients with suicidal behavior. It is also considered in the patients with treatment resistant cases of bipolar disorder. It is also used for the cases of acute schizophrenia.

This treatment is considered for the cases of schizophrenia patients who show minimal or no response to the antipsychotic medications. ECT is also recommended for the treatment of obsessive-compulsive disorder (OCD), catatonia, depression associated with Parkinson diseases, pain and acute confusion psychosis.

The increasing cases of mental illness due to brain injuries, Bacterial infections causing mental disorders and increasing long term use of substance abuse linked to depression and anxiety is expected to increase the usage of ECT device.

Changing life style and increasing exposure to harmful toxins is expected to attribute to the increasing usage of the device. The prevalence rate of schizophrenia was approximately 1.1% for the 18 years and above population in 2010. As per the report of the National Alliance on Mental Illness, 1 out of 5 adults in the US experience mental illness.

Growing incidence of mental disorders and demand for treatment options for severe mental illness are the factors driving the growth of global electroconvulsive therapy devices market . Advancements in technology and development for study of brain is believed to play the crucial role in the growth of global electroconvulsive therapy devices market over the forecast period. 

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/12127 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl